SHORT WAVE PHARMA SIGNS CLINICAL TRIAL AGREEMENT WITH THE SHEBA RESEARCH FUND AND THE SHEBA CENTER FOR EATING DISORDERS ...Middle East

TORONTO and RAMAT-GAN, Israel, Aug. 15, 2022 /PRNewswire/ -- Short Wave Pharma Inc. ("Shortwave" or the "Company"), a biopharmaceutical company developing patent pending psychedelic compositions and methods of delivery, is pleased to announce that it has signed a Clinical Trial Agreement...

Hence then, the article about short wave pharma signs clinical trial agreement with the sheba research fund and the sheba center for eating disorders was published today ( Monday 15/08/2022 - 12:28 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SHORT WAVE PHARMA SIGNS CLINICAL TRIAL AGREEMENT WITH THE SHEBA RESEARCH FUND AND THE SHEBA CENTER FOR EATING DISORDERS )

Also on site :

• ‘PLA built roads, camps inside India’: Border tribe alleges Chinese land grab in Arunachal
• Burnham latest: Makerfield MP vows to ‘lift Britain back up’ with radical 10-year plan to raise living standards
• Dangerous and potentially record-setting heat wave to scorch millions this July Fourth